
Because pharmacy benefit managers and third-party administrators earn more from arrangements with smaller safety-net providers, there are incentives to shift attribution of prescriptions toward those providers.

Neal Masia, Ph.D., is an adjunct professor of business and economics at Columbia University, co-founder and CEO of EntityRisk and a consultant and advisor to a variety of healthcare companies.